P3 Health Partners (NASDAQ:PIII – Get Free Report) and Tivic Health Systems (NASDAQ:TIVC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, profitability and institutional ownership.
Analyst Recommendations
This is a summary of current recommendations for P3 Health Partners and Tivic Health Systems, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| P3 Health Partners | 1 | 1 | 1 | 0 | 2.00 |
| Tivic Health Systems | 1 | 0 | 0 | 0 | 1.00 |
P3 Health Partners currently has a consensus price target of $12.50, indicating a potential upside of 253.11%. Given P3 Health Partners’ stronger consensus rating and higher possible upside, equities analysts plainly believe P3 Health Partners is more favorable than Tivic Health Systems.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| P3 Health Partners | -9.07% | -302.33% | -16.72% |
| Tivic Health Systems | -1,557.26% | -202.20% | -173.34% |
Risk and Volatility
P3 Health Partners has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 1.97, indicating that its stock price is 97% more volatile than the S&P 500.
Insider and Institutional Ownership
7.8% of P3 Health Partners shares are held by institutional investors. Comparatively, 4.3% of Tivic Health Systems shares are held by institutional investors. 17.8% of P3 Health Partners shares are held by company insiders. Comparatively, 0.5% of Tivic Health Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares P3 Health Partners and Tivic Health Systems”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| P3 Health Partners | $1.50 billion | 0.02 | -$135.85 million | ($40.18) | -0.09 |
| Tivic Health Systems | $780,000.00 | 3.56 | -$5.66 million | ($6.68) | -0.24 |
Tivic Health Systems has lower revenue, but higher earnings than P3 Health Partners. Tivic Health Systems is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
Summary
P3 Health Partners beats Tivic Health Systems on 9 of the 14 factors compared between the two stocks.
About P3 Health Partners
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
About Tivic Health Systems
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.
